Evidence map›Paper›PMID 39068257›Full record

ArticleCommunications biology2024

Peri active site catalysis of proline isomerisation is the molecular basis of allomorphy in β-phosphoglucomutase.

F Aaron Cruz-Navarrete, Nicola J Baxter, Adam J Flinders, Anamaria Buzoianu, Matthew J Cliff, Patrick J Baker, Jonathan P Waltho

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

F Aaron Cruz-Navarrete *School of Biosciences, University of Sheffield, Sheffield, S10 2TN, UK.ORCID 0000-0002-5233-581X
Nicola J Baxter *School of Biosciences, University of Sheffield, Sheffield, S10 2TN, UK.ORCID 0009-0000-8292-7800
Adam J FlindersSchool of Biosciences, University of Sheffield, Sheffield, S10 2TN, UK.
Anamaria BuzoianuSchool of Biosciences, University of Sheffield, Sheffield, S10 2TN, UK.
Matthew J CliffManchester Institute of Biotechnology and Department of Chemistry, The University of Manchester, Manchester, M1 7DN, UK.ORCID 0000-0002-7482-0234
Patrick J BakerSchool of Biosciences, University of Sheffield, Sheffield, S10 2TN, UK.ORCID 0000-0003-1995-5643
Jonathan P WalthoSchool of Biosciences, University of Sheffield, Sheffield, S10 2TN, UK. j.waltho@sheffield.ac.uk.ORCID 0000-0002-7402-5492

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic regulation occurs through precise control of enzyme activity. Allomorphy is a post-translational fine control mechanism where the catalytic rate is governed by a conformational switch that shifts the enzyme population between forms with different activities. β-Phosphoglucomutase (βPGM) uses allomorphy in the catalysis of isomerisation of β-glucose 1-phosphate to glucose 6-phosphate via β-glucose 1,6-bisphosphate. Herein, we describe structural and biophysical approaches to reveal its allomorphic regulatory mechanism. Binding of the full allomorphic activator β-glucose 1,6-bisphosphate stimulates enzyme closure, progressing through NAC I and NAC III conformers. Prior to phosphoryl transfer, loops positioned on the cap and core domains are brought into close proximity, modulating the environment of a key proline residue. Hence accelerated isomerisation, likely via a twisted anti/C4-endo transition state, leads to the rapid predominance of active cis-P βPGM. In contrast, binding of the partial allomorphic activator fructose 1,6-bisphosphate arrests βPGM at a NAC I conformation and phosphoryl transfer to both cis-P βPGM and trans-P βPGM occurs slowly. Thus, allomorphy allows a rapid response to changes in food supply while not otherwise impacting substantially on levels of important metabolites.

Indexed as

Catalytic DomainPhosphoglucomutaseProlineCatalysisGlucose-6-PhosphateGlucosephosphatesHumansIsomerismModels, MolecularProtein Conformationglucose-1,6-bisphosphateglucose-1-phosphateGlucose-6-PhosphateGlucosephosphatesPhosphoglucomutaseProline

Identifiers

PMID39068257
PMCPMC11283535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.